Search results
5 million doses of vaccine against H5N1 avian flu being prepared
United Press International via Yahoo News· 11 hours agoAs the H5N1 avian flu continues to spread among dairy cows in the United States, nearly 5 million...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 20 hours agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented the latest...
U.S. to make millions of bird flu vaccine doses this summer
WLTX-TV Columbia· 8 hours agoSome 4.8 million doses of flu vaccine are now being prepared for use in response to the growing U.S. outbreak of highly pathogenic avian influenza, or H5N1, officials say.
The COVID-19 Vaccines Shouldn't Have Been Free
Reason.com via Yahoo News· 5 days agoTo correct these errors for future pandemic responses, Prasad and Haslam recommend performing larger vaccine trials and collecting better data on vaccine
Small Business - Picayune Item | Picayune Item
The Picayune Item· 29 minutes agoGHENT, Belgium, June 04, 2024 (GLOBE NEWSWIRE) -- ExeVir Bio, a biotech company developing robust heavy chain-only antibody therapies for broad protection against infectious diseases, today announced new data demonstrating that its antibodies
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 3 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 22 hours agoLaunching mResvia won't be easy In May 2023, the FDA approved Arexvy, a respiratory syncytial virus...
Study: High excess death rates in the West for 3 years running since start of pandemic despite...
Medical Xpress· 9 hours agoExcess death rates have remained high in the West for three years running since the start of the COVID-19 pandemic, finds a data analysis of 47 countries published in BMJ Public Health. This ...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 20 hours agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...
HPV vaccine can reduce risk of multiple cancers in men, new study suggests
ABC News via Yahoo News· 5 days agoNearly two decades after the launch of the first HPV vaccine, mounting evidence shows that people...
